NASDAQ · SERVICES-ADVERTISING AGENCIES · SMALL CAP
Haoxi Health Technology Limited HAO
4 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$32.8M
▼ 32.4% vs FY2023
EPS · FY24
—
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
27.1%
Net margin · FY24
11.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 32.8M
Revenue, FY2024 · full 4-year series below
Revenue
Net income
12 cents of every revenue dollar became profit this year.
Per share
—
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
27.1%
Return on equity, FY2024
ROE
Operating margin-6.1%
Net margin11.8%
Return on assets20.9%
Each USD of equity produced 27 cents of profit this year.
Returned to shareholders
—
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+26.6%
Net income
+151.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2024
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 21.6M
total assets, end of FY2024
Total assetsUSD 21.6M
EquityUSD 17.4M
CashUSD 8.6M
Gross debtUSD 607,661.00
Net debtUSD -8.0M
Current ratio5.05×
The company holds more cash than debt.
History
4 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
Revenue $B
0.0
0.0
0.0
0.0
Operating income $B
−0.0
0.0
0.0
0.0
EBITDA $B
−0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
Net income $B
0.0
0.0
0.0
0.0
EPS, diluted $
·
·
·
·
Dividend / sh $
·
·
·
·
Payout %
·
·
·
·
ROE %
27.1
20.1
1923.7
·
Shares out B
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
14 of 14
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed